Skip to content

Clinical trials

Phase 2 Connective Tissue Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Connective Tissue Diseases Phase: Phase 2 Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20111
20131
20171
20182
20192
20201
20211
20223
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated5
Active, not recruiting3
Recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Caliway Biopharmaceuticals Co., Ltd.2
Complexa, Inc.2
National Center for Research Resources (NCRR)2
Alumis Inc1
Amgen1
Bastiaan Driehuys1
Beeline Medicines Corporation1
Children's Hospital Medical Center, Cincinnati1
Cumberland Pharmaceuticals1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Connective Tissue Diseases23
Arthritis8
Rare Diseases7
Immune System Diseases6
Autoimmune Diseases5
Skin Diseases5
Lupus Erythematosus, Systemic4
Scleroderma, Systemic4
Cardiovascular Diseases3
Familial Primary Pulmonary Hypertension3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.